Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology

被引:247
作者
Chakrabarti, S
Patel, KD
机构
[1] Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada
[2] Univ Calgary, Dept Biochem & Mol Biol, Immunol Res Grp, Calgary, AB, Canada
关键词
asthma; COPD; gelatinase; lung; neutrophil; remodeling;
D O I
10.1080/019021490944232
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The lung is affected by a variety of disease processes that can lead to considerable morbidity and mortality. As the lung is the only organ for respiration and gas exchange, the structural and functional integrity of the lung is of primary importance. Various pathological processes affect the extracellular matrix (ECM) of the lung in an adverse manner, causing destruction of tissue integrity followed by tissue remodeling, which together impair normal pulmonary function. Matrix metalloproteinases (MMPs) are neutral proteinases that are involved in the breakdown and remodeling of the ECM under a variety of physiological and pathological conditions. MMP-2 and MMP-9, collectively known as the gelatinases, are particularly important in the pathogenesis of inflammatory, infectious, and neoplastic diseases in many organs including the lung. This review examines the expression of MMP-2 and MMP-9 in disease of the lung and discusses the role these gelatinases may play in disease progression.
引用
收藏
页码:599 / 621
页数:23
相关论文
共 127 条
[31]  
Fukuda Y, 1998, LAB INVEST, V78, P687
[32]  
Gatto C, 1999, CLIN CANCER RES, V5, P3603
[33]   PROCESSING OF TUMOR-NECROSIS-FACTOR-ALPHA PRECURSOR BY METALLOPROTEINASES [J].
GEARING, AJH ;
BECKETT, P ;
CHRISTODOULOU, M ;
CHURCHILL, M ;
CLEMENTS, J ;
DAVIDSON, AH ;
DRUMMOND, AH ;
GALLOWAY, WA ;
GILBERT, R ;
GORDON, JL ;
LEBER, TM ;
MANGAN, M ;
MILLER, K ;
NAYEE, P ;
OWEN, K ;
PATEL, S ;
THOMAS, W ;
WELLS, G ;
WOOD, LM ;
WOOLLEY, K .
NATURE, 1994, 370 (6490) :555-557
[34]   N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease [J].
Gerrits, CMJM ;
Herings, RMC ;
Leufkens, HGM ;
Lammers, JWJ .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (05) :795-798
[35]  
GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583
[36]  
Golub L M, 1998, Adv Dent Res, V12, P12
[37]   In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: Relationship to bone and cartilage degradation [J].
Greenwald, RA ;
Golub, LM ;
Ramamurthy, NS ;
Chowdhury, M ;
Moak, SA ;
Sorsa, T .
BONE, 1998, 22 (01) :33-38
[38]   Pulmonary matrix metalloproteinase excess in hospital-acquired pneumonia [J].
Hartog, CM ;
Wermelt, JA ;
Sommerfeld, CO ;
Eichler, W ;
Dalhoff, K ;
Braun, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (04) :593-598
[39]   Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors [J].
Heath, EI ;
O'Reilly, S ;
Humphrey, R ;
Sundaresan, P ;
Donehower, RC ;
Sartorius, S ;
Kennedy, MJ ;
Armstrong, DK ;
Carducci, MA ;
Sorensen, JM ;
Kumor, K ;
Kennedy, S ;
Grochow, LB .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (04) :269-274
[40]   Development of matrix metalloproteinase inhibitors in cancer therapy [J].
Hidalgo, M ;
Eckhardt, SG .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (03) :178-193